9/11/2019 4:19:57 PM
Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.41, Record Date 10/4/2019
9/11/2019 4:19:31 PM
Bristol-Myers Squibb Declares Quarterly Dividend Of $0.41/share, Payable Nov. 1/ Record Oct. 4
9/5/2019 7:08:03 AM
Bristol-Myers Squibb Updates On Phase 3 Opdivo CheckMate -548 Trial
9/4/2019 7:02:33 AM
BioMotiv And Bristol-Myers Squibb Form Strategic Partnership
8/27/2019 8:03:15 AM
Presage Enters Research Collaboration With Bristol-Myers To Evaluate Early Stage Oncology Targets In Phase 0 Trials
8/26/2019 6:32:26 AM
Amgen To Acquire Otezla For $13.4 Bln In Cash
8/5/2019 8:03:12 AM
PTC Therapeutics Signs Long-term Lease Agreement With Bristol-Myers Squibb
8/1/2019 7:24:38 AM
Nektar, Bristol-Myers Announce FDA Breakthrough Therapy Designation For NKTR-214 In Combination With Opdivo
7/26/2019 7:10:31 AM
Bristol-Myers Squibb Gets Positive CHMP Opinion Regarding Approval Of Empliciti
7/25/2019 9:25:54 AM
Bristol-Myers Squibb Co. (BMY) Has Raised Its 2019 EPS Estimate To 4.20 - 4.30 From 4.10 - 4.20
7/25/2019 7:04:28 AM
Bristol-Myers Squibb Q2 Non-GAAP EPS $1.18 Vs $1.01 Last Year